Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Haploinsufficiency | 4 | 2022 | 62 | 1.910 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2016 | 763 | 1.330 |
Why?
|
| Chromosome Deletion | 4 | 2020 | 229 | 1.190 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2022 | 54 | 1.170 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 91 | 1.090 |
Why?
|
| Genes, APC | 2 | 2017 | 26 | 1.070 |
Why?
|
| Clathrin | 4 | 2011 | 29 | 0.900 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2017 | 346 | 0.900 |
Why?
|
| Bone Marrow | 2 | 2020 | 435 | 0.760 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 292 | 0.750 |
Why?
|
| Neoplasms, Second Primary | 3 | 2020 | 252 | 0.720 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 138 | 0.710 |
Why?
|
| Leukemia, Myeloid | 2 | 2020 | 249 | 0.710 |
Why?
|
| Genes, p53 | 2 | 2020 | 109 | 0.650 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 90 | 0.620 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 21 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 109 | 0.580 |
Why?
|
| Peptide Termination Factors | 1 | 2016 | 5 | 0.560 |
Why?
|
| Retroviridae | 1 | 2016 | 79 | 0.540 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 111 | 0.530 |
Why?
|
| Wnt Proteins | 1 | 2015 | 123 | 0.520 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2005 | 113 | 0.510 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 379 | 0.470 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 40 | 0.470 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 532 | 0.430 |
Why?
|
| Carrier Proteins | 1 | 2015 | 673 | 0.420 |
Why?
|
| Mice | 8 | 2022 | 11352 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 381 | 0.400 |
Why?
|
| B-Lymphocytes | 3 | 2005 | 724 | 0.380 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 128 | 0.380 |
Why?
|
| Proteins | 1 | 2016 | 777 | 0.370 |
Why?
|
| Ethylnitrosourea | 2 | 2022 | 30 | 0.340 |
Why?
|
| Membrane Microdomains | 3 | 2005 | 54 | 0.300 |
Why?
|
| Animals | 11 | 2022 | 26582 | 0.290 |
Why?
|
| Mutation | 1 | 2015 | 3968 | 0.250 |
Why?
|
| Antigens, CD34 | 1 | 2022 | 158 | 0.210 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1540 | 0.180 |
Why?
|
| Stromal Cells | 1 | 2020 | 143 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3092 | 0.170 |
Why?
|
| Endocytosis | 2 | 2011 | 177 | 0.150 |
Why?
|
| Pyrvinium Compounds | 1 | 2017 | 5 | 0.150 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 55 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 418 | 0.150 |
Why?
|
| Inflammation | 1 | 2022 | 920 | 0.150 |
Why?
|
| Humans | 11 | 2022 | 86643 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 229 | 0.140 |
Why?
|
| beta Catenin | 1 | 2017 | 251 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1924 | 0.130 |
Why?
|
| AT Rich Sequence | 1 | 2014 | 7 | 0.120 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 19 | 0.120 |
Why?
|
| Anemia, Macrocytic | 1 | 2013 | 5 | 0.120 |
Why?
|
| Biological Transport, Active | 2 | 2005 | 102 | 0.120 |
Why?
|
| Genes, Lethal | 1 | 2013 | 53 | 0.120 |
Why?
|
| Erythroblasts | 1 | 2013 | 25 | 0.120 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 27 | 0.120 |
Why?
|
| Erythropoiesis | 1 | 2013 | 52 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2014 | 98 | 0.120 |
Why?
|
| Heterozygote | 1 | 2013 | 365 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 329 | 0.110 |
Why?
|
| Spleen | 1 | 2013 | 430 | 0.110 |
Why?
|
| Cell Line | 3 | 2014 | 2468 | 0.110 |
Why?
|
| Receptors, Growth Factor | 1 | 2011 | 52 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 427 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 79 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2232 | 0.090 |
Why?
|
| Alleles | 1 | 2013 | 1128 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2011 | 173 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2009 | 71 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1208 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 736 | 0.090 |
Why?
|
| Histones | 1 | 2011 | 311 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1135 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1047 | 0.080 |
Why?
|
| Genotype | 1 | 2013 | 1851 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2818 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2016 | 1565 | 0.080 |
Why?
|
| Apoptosis | 1 | 2013 | 1683 | 0.070 |
Why?
|
| src-Family Kinases | 2 | 2004 | 74 | 0.070 |
Why?
|
| Aged | 1 | 2022 | 18415 | 0.070 |
Why?
|
| Ligands | 2 | 2004 | 433 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2004 | 209 | 0.060 |
Why?
|
| Actins | 2 | 2005 | 451 | 0.060 |
Why?
|
| Phenotype | 1 | 2011 | 2378 | 0.060 |
Why?
|
| Chickens | 1 | 2005 | 212 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2004 | 135 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2004 | 1106 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2004 | 3241 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1014 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 302 | 0.060 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 8 | 0.030 |
Why?
|
| Granulocytes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Male | 2 | 2015 | 40965 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 236 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2014 | 163 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 214 | 0.030 |
Why?
|
| Female | 1 | 2015 | 44532 | 0.030 |
Why?
|
| Azo Compounds | 1 | 1989 | 13 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1989 | 49 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1989 | 79 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1384 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1920 | 0.020 |
Why?
|
| Immune Sera | 1 | 2004 | 52 | 0.020 |
Why?
|
| Transferrin | 1 | 2004 | 19 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 86 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 222 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 411 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2426 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1989 | 88 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1989 | 118 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1989 | 373 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 989 | 0.000 |
Why?
|
| Kinetics | 1 | 1989 | 1513 | 0.000 |
Why?
|
| Rats | 1 | 1989 | 3990 | 0.000 |
Why?
|